Background: Sinistral portal hypertension (SPH) may occur in patients with pancreatic carcinoma after pancreaticoduodenectomy (PD) with spleno-mesenterico-portal (S-M-P) confluence resection. This study aimed to evaluate outcomes with bifurcated allogeneic vein replacement in the prevention of SPH in pancreatic carcinoma patients. Materials and methods: A total of 81 patients were included. The authors retrospectively collected clinicopathological data from 66 patients underwent PD with S-M-P confluence resection in our hospital from January 2011 to December 2021, compared the correlation between different venous reconstruction methods using log-rank tests and clinical outcomes through univariate and multivariate analyses. Secondly, the authors prospectively collected clinical data and outcomes of 15 patients who underwent splenic vein reconstruction from January 2021 to January 2023. Results: In the retrospective study, 43 cases received reconstruction by bifurcated allogeneic vein (Reconstruction group) and 23 cases received simply SV ligation (Ligation group). The preoperative platelet counts and spleen volume were similar between two groups ( P >0.05). Nevertheless, at 1 month, 3 months and 6 months after operation, the related indexes of SPH such as platelet count, spleen volume, spleen volume ratio and esophagogastric varices (EGV) grade in Reconstruction group were better than those in Ligation group ( P <0.05). 6 months after surgery, the incidence of SPH in Ligation group was significantly higher than in Reconstruction group (36.4% vs. 8.1%, respectively). In the prospective study, the incidence of SPH in patients undergoing SV reconstruction was 6.7% (1/15). Conclusions: Without compromising surgical outcomes, reconstruction of the S-M-P confluence by bifurcated allogeneic vein is a better method to avoid SPH in patients with advanced pancreatic carcinoma.
Background: Neutrophil extracellular traps (NETs) play a crucial role in thrombosis formation and tumor progression. However, the association between NETs and portal vein thrombosis (PVT) is not well understood. Methods: We retrospectively and prospectively developed and validated a predictive model for postoperative PVT following radical surgery for pancreatic ductal adenocarcinoma (PDAC) from Jan. 2011 to Dec. 2022 and Jan. 2023 to Dec. 2023. 30 clinicopathological variables, including the novel biomarker NETs, were evaluated. 11 ML algorithms were compared based on several evaluation indexes including AUC. SHapley Additive exPlanations (SHAP) analysis was utilized for feature ranking and interpretability. Results: In the retrospective study, a total of 306 patients were included, among which 70 (22.9%) developed PVT. In the prospective study, a total of 64 patients were enrolled and the incidence of PVT was 25%. eXtreme gradient boosting (XGBoost) demonstrated superior discriminative performance among 11 evaluated ML-models. After feature reduction based on ranked feature importance, a final interpretable XGBoost model comprising 7 variables was established. This model accurately predicted postoperative PVT in both training (AUC = 0.906) and validation (AUC = 0.823) cohorts, and has been translated into a convenient tool to facilitate its utility in clinical settings. Conclusion: In patients with PDAC, higher NETs levels are correlated with an increased risk of developing PVT and are indicative of poor prognosis. Assessment of Cit-H3 and D-dimer levels may aid clinicians in predicting PVT.